How are TaiMed, Theratechnologies, and Trogarzo connected?
TaiMed states that Theratechnologies is its exclusive commercialization partner for Trogarzo (ibalizumab-uiyk) in the United States, with the U.S. and Canada marketing and distribution agreement remaining in effect in its 2025 acquisition-related announcement. taimedbiologics.com (read 2026-10-29)